← Open Payments lookup

SHARON LEVY: Open Payments

NPI 1316396807 · SAN MARCOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,218 in 49 payments from 16 companies in 2025. Trend: 2023 $723 · 2024 $1,059 · 2025 $1,218

Food & beverage: $1,218
CompanyPaymentsAmount
GlaxoSmithKline, LLC.17$304
GENZYME CORPORATION6$212
Regeneron Healthcare Solutions, Inc.1$118
Novartis Pharmaceuticals Corporation4$85
Pharming Healthcare, Inc.3$71
CSL Behring3$68
ARS Pharmaceuticals Operations, Inc.3$63
Takeda Pharmaceuticals U.S.A., Inc.2$60
Grifols USA, LLC2$48
Octapharma USA, Inc.1$37

Products named: NUCALA, DUPIXENT, TRELEGY ELLIPTA, RUCONEST, NEFFY, Xembify, Hizentra, PANZYGA.

Industry payments across CA — which companies pay providers there.